STEPHANIE SPITERY: Open Payments
NPI 1356944490 · NEW HUDSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 35 payments from 15 companies in 2025. Trend: 2023 $420 · 2024 $540 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Radius Health, Inc. | 5 | $110 |
| ABBVIE INC. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Amgen Inc. | 2 | $41 |
| Alkermes, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: REXULTI, Tymlos, CAPLYTA, VRAYLAR, Kerendia, QULIPTA, LYBALVI, FANAPT.
Industry payments across MI — which companies pay providers there.
